A request for registration of a multisource generic medication to the List of Medications for the basic prescription drug insurance plan or the List of Medications – Institutions may be processed in priority for economic reasons.
Pursuant to the Pharmaceutical Policy, a multisource generic medication may be subject to a priority evaluation if its registration is conducive to bringing significant savings to the public health care system.
The potential savings threshold for a medication to be prioritised for economic reasons is established annually. For 2021, this threshold was set at $200,000 per month for anticipated registrations.
The deadlines for the receipt of requests for priority evaluation of multisource generic drug products for economic reasons are:
|Next update||Deadline for receipt of requests for priority evaluation (generics drugs)|
|February 3, 2021||November 25, 2020|
|March 3, 2021||January 6, 2021|
|April 14, 2021||February 17, 2021|
|May 27, 2021||March 31, 2021|
|July 7, 2021||May 12, 2021|
|August 18, 2021||June 23, 2021|
|September 29, 2021||August, 4 2021|
|November 10, 2021||September 15, 2021|
|December 15, 2021||October 20, 2021|